
Bioceres Crop Solutions fell 87.7% from $1.93 to $0.24, behind the S&P 500's +9.8%. Its worst day was Feb 3 (−32.9%), and its low came Nov 5 at $0.21.
Nov 11, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.12 missed the $-0.07 estimate on $77.3M revenue (est. $92.0M).
−8.6% · S&P 500 −1.7%
Bioceres Crop Solutions shares fell 32.9%, while the S&P 500 fell 0.8%.
Story events cover the past 12 months · Times ET
−32.9%, the year's worst day · S&P 500 −0.8%
Bioceres Crop Solutions shares fell 18.0%, while the S&P 500 rose 0.1%.
−18.0% · S&P 500 +0.1%
EPS of $-0.08 missed the $-0.05 estimate on $73.7M revenue (est. $54.5M).
−17.5% · S&P 500 +1.0%
EPS of $-0.16 missed the $-0.05 estimate on $39.4M revenue (est. $54.5M).
−16.9% · S&P 500 −0.2%
EPS of $-0.50 missed the $-0.06 estimate on $55.9M revenue (est. $79.0M).
−5.5% · S&P 500 −0.5%
Where it ended: a close of $0.24 on Nov 9, 2026. Up next: Q1 2027 earnings on Nov 24, 2026 (EPS est. $-0.10).
Nothing in the past 12 months.
All BIOX dividend historyReplay the year: the line draws itself and stops at each of the 6 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for BIOX and SPY from Benzinga historical bars. Not investment advice.